Gland Pharma reports nearly 50% jump in Q1 profit Ruchika Sharma7 Aug 2025 10:00 AM ISTHyderabad-based Gland Pharma has posted a nearly 50 percent surge in first-quarter profit, driven by improved margins and a recovery at its European...
Aster DM Healthcare, India appoints Sudeep Dey as CIO, CISO Ruchika Sharma6 Aug 2025 4:39 PM ISTAster DM Healthcare, India, has appointed Sudeep Dey as its new Chief Information Officer (CIO) and Chief Information Security Officer...
No Waiver for Faricimab: CDSCO Panel Asks Roche to Conduct Phase III Trial in India Parthika Patel6 Aug 2025 3:34 PM ISTNew Delhi: Roche Products (India) Pvt Ltd has been directed by the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation...
Zydus Wellness incorporates wholly owned subsidiary in UK Ruchika Sharma6 Aug 2025 3:31 PM ISTAhmedabad: Zydus Wellness Limited has announced the incorporation of a wholly owned subsidiary named Alidac UK Limited in the United Kingdom,...
Teva Pharma announces USFDA filing acceptance for Ajovy in Pediatric Episodic Migraine prevention Ruchika Sharma6 Aug 2025 12:38 PM ISTParsippany: Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd., has announced that the U.S. Food and Drug...
Sanofi completes acquisition of Vigil Neuroscience Ruchika Sharma6 Aug 2025 11:30 AM ISTParis: Sanofi announces the completion of its acquisition of Vigil Neuroscience, Inc. This acquisition strengthens Sanofi's early-stage pipeline...
Akum Pharma Asked to Submit Safety Data for Alzheimer's Drug Combo In Elderly Indian Patients Dr. Divya Colin5 Aug 2025 5:31 PM ISTNew Delhi: In a recent regulatory review, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO)...
Aurobindo Pharma net profit drops 10 percent to Rs 824 crore in Q1 MD Bureau5 Aug 2025 4:28 PM ISTMumbai: Aurobindo Pharma Ltd has posted a 10.2 percent year-on-year (YoY) decline in consolidated net profit for the first quarter of FY26, with...
MSN Labs Gets CDSCO Panel Nod to Begin Phase III Trial of Cenobamate Tablets, With Safety Caveat Dr. Divya Colin5 Aug 2025 4:15 PM ISTNew Delhi: Considering the bioequivalence study results of the MSN Labs Cenobamate Tablets 12.5 mg, 25 mg, 50mg, 100 mg, 150 mg & 200 mg, the...
USFDA appoints Sean Keveney as Chief Counsel Ruchika Sharma5 Aug 2025 1:45 PM ISTWashington: The U.S. Department of Health and Human Services (HHS) and U.S. Food and Drug Administration (FDA) have announced that Sean Keveney...
Bristol Myers Squibb Breyanzi application accepted for priority review by USFDA for Marginal Zone Lymphoma Ruchika Sharma5 Aug 2025 12:20 PM ISTPrinceton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental biologics license...
Cipla Bommasandra facility gets VAI classification from USFDA Ruchika Sharma5 Aug 2025 11:54 AM ISTMumbai: Cipla has announced that the United States Food and Drug Administration (USFDA) has classified the current Good Manufacturing Practices (cGMP)...
